Cargando…
Controversy about pharmacological modulation of Nrf2 for cancer therapy
Conventional anticancer therapies such as radiotherapy and chemotherapies are associated with oxidative stress generating reactive oxygen species (ROS) and reactive aldehydes like 4-hydroxynonenal in cancer cells that govern them to die. The main mechanism activated due to exposure of the cell to th...
Autores principales: | Milkovic, Lidija, Zarkovic, Neven, Saso, Luciano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393166/ https://www.ncbi.nlm.nih.gov/pubmed/28411557 http://dx.doi.org/10.1016/j.redox.2017.04.013 |
Ejemplares similares
-
The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
por: Jaganjac, Morana, et al.
Publicado: (2020) -
Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response
por: Gall Trošelj, Koraljka, et al.
Publicado: (2022) -
Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects 2017
por: Saso, Luciano, et al.
Publicado: (2017) -
The 4-Hydroxynonenal–Protein Adducts and Their Biological Relevance: Are Some Proteins Preferred Targets?
por: Milkovic, Lidija, et al.
Publicado: (2023) -
Short Overview of ROS as Cell Function Regulators and Their Implications in Therapy Concepts
por: Milkovic, Lidija, et al.
Publicado: (2019)